TABLE 2.
Target disease | Model | Probiotic | Treatment effect | Mechanism | Refs |
---|---|---|---|---|---|
IBS | Male Sprague–Dawley rats, water chronic exposure | Bifidobacterium longum | Improved defecation habits, visceral ↓hypersensitivity, ↑mucosal repair | ↑Lysozyme production, ↑stem niche factors WNT3A and TGF‐β | 114 |
IBD | Female C57BL/6N mice, DSS induced | Limosilactobacillus fermentum KBL374 | ↑Colon length, ↓inflammatory cytokines, ↑body weight, ↓leukocyte infiltration | Regulating immune responses, altering gut microbiota, ↑gut barrier function | 113 |
CRC | Male C57BL/6 ‐APCMin/+, DSS induced | L. plantarum YYC‐3 | ↓Occurrence of colon tumors and mucosal damage, ↓inflammatory cytokines, ↓VEGF‐MMP2/9 signaling pathway | Immunomodulation, altered gut microbiota, secreted metabolites | 138 , 139 |
Melanoma | C57BL/6 WT mice, breast cancer cells induced | Lactobacillus reuteri | ↑ICI efficacy, promoting ICI response and patients survival | Secretes indole‐3‐aldehyde to stimulate CD8+ T cells | 140 |
Infection | Female C57BL/6J mice, S. aureus and antibiotics induced | Bacillus subtilis ZK3814 | Eliminates S. aureus, suppressed production of Agr‐regulated virulence factors | ZK3814 secretes fengycins inhibit quorum sensing | 120 |
Autism spectrum disorders | Shank3 KO mice | L. reuteri | Modifies social and repetitive behaviors, ↓GABA receptor expression, ↑hypothalamic expression of oxytocin | Brain–gut axis | 141 |
Depression | Male ICR mice, loperamide induced | Compound probiotics | Ameliorate depressive behaviors, ↓neuronal cell injury, ↓Bax and cleaved caspase‐3, ↑p‐AKT and Bcl‐2 levels | Activating the AKT signaling pathway | 142 |
Alcoholic liver disease | Male C57BL/6 mice, alcohol induced | Bifidobacterium breve ATCC15700 | ↓Endotoxemia, maintained immune homeostasis, alleviated liver injury, ↑tight junction proteins | Promoted intestinal barrier function, regulate gut microbiota | 143 |
Hyperuricemia | Male Kunming mice, oteracil potassium and UA‐induced | Limosilactobacillus fermentum JL‐3 | ↓Serum UA level (31.3%), ↓oxidative stress indicators | Degrade uric acid, regulate gut microbiota | 126 |
Chromate poisoning | Female Kuming mice, Cr (VI) induced | Pediococcus acidilactici strain BT36 | ↓Chromate accumulation, ↓oxidative stress | Promotes chromium excretion, regulate gut microbiota | 131 |
Kidney stones | Male Rattus novergicus, calcium oxalate induced | L. casei 01 | Attenuates the development of renal calculi | Degrade and utilize oxalate | 144 |
Toxins | Male ICR mice, aflatoxin B1 gavage | L. plantarum T3 | ↑Aflatoxin B1 excretion, ameliorate oxidative stress and immune imbalance | Removal aflatoxin B1 by cell adsorption, restore gut homeostasis | 145 |
Diabetic | Male Kunming mice, glucose induced | Compound probiotics | ↓Blood glucose, ↓SGLT‐1 and GLUT‐2 expression, ↓intestinal permeability | Probiotics competitively consume glucose | 146 |
Abbreviations: AKT, protein kinase B;CRC, colorectal cancer; GLUT‐2, glucose transporter 2.; SGLT‐1, recombinant sodium/glucose cotransporter 1.